Reported Friday, CareMax Q2 2024 Adj. EPS $(9.86) Misses $(6.86) Estimate, Sales $198.627M Miss $206.928M Estimate
Portfolio Pulse from Benzinga Newsdesk
CareMax (NASDAQ:CMAX) reported Q2 2024 adjusted EPS of $(9.86), missing the $(6.86) estimate by 43.73%. Sales were $198.627M, missing the $206.928M estimate by 4.01%. This represents a 134.76% increase in losses and an 11.50% decrease in sales compared to the same period last year.
August 12, 2024 | 6:12 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
CareMax reported Q2 2024 adjusted EPS of $(9.86), significantly missing the $(6.86) estimate. Sales also missed expectations, coming in at $198.627M versus the $206.928M estimate. The company saw a 134.76% increase in losses and an 11.50% decrease in sales compared to the same period last year.
The significant miss on both EPS and sales estimates, along with a substantial increase in losses and a decrease in sales compared to the previous year, is likely to negatively impact CareMax's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100